Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Afimkibart (RO7790121) in children with moderately to severely active ulcerative colitis, with recruitment ongoing to ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Afimkibart (RO7790121)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Moderately to Severely Active Ulcerative Colitis | Phase 3 | Status: RECRUITING